Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region
      Biotech

      Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region

      February 13, 2025
      Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
      Biotech

      Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025

      February 12, 2025
      Desert Control Releases Q4 2024 Report and Year-to-Date Company Update
      Biotech

      Desert Control Releases Q4 2024 Report and Year-to-Date Company Update

      February 12, 2025
      Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China
      Biotech

      Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China

      February 11, 2025
      GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025
      Biotech

      GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025

      February 11, 2025
      dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion
      Biotech

      dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

      February 11, 2025
      Foresee Pharmaceuticals Announces Acceptance of An Abstract for Presentation at ASCO Genitourinary Cancers Symposium 2025
      Biotech

      Foresee Pharmaceuticals Announces Acceptance of An Abstract for Presentation at ASCO Genitourinary Cancers Symposium 2025

      February 10, 2025
      AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray
      Biotech

      AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray

      February 10, 2025
      Government of Canada invests $6 million to drive growth in B.C.’s life sciences sector
      Biotech

      Government of Canada invests $6 million to drive growth in B.C.’s life sciences sector

      February 8, 2025
      Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence
      Biotech

      Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence

      February 8, 2025
      « 1 … 49 50 51 52 53 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026